Replies to post #16704 on Endonovo Therapeutics Inc (ENDV)

[Stiggie]

Please reread the original press release from then.

They stated that it is their intention to begin pre-clinical testing of its electroceutical technology.

The one from 2017:
...today announced it is commencing a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in preventing and reversing inflammation in Non-Alcoholic Steatohepatitis (NASH).

Huge differences between the 2. Having the intention does not mean they did the study. I intent to be a millionaire someday, but that does not mean that I will be. :)

[Compsource1]

Completely agree that communication needs to improve. But honestly, what do you want them to say? They communicated recently and nobody liked the honesty...they're just not there yet and it's taking longer than expected. Mann continues to buy and he is deeper in the red than anyone here. Approaching ~22m shares. He's the closest to the flame and he continues to load. Timing is a guess...it could be today, could be next week, could be a month...for now, its dilution, manipulation, frowns and know-it-alls, IMO. Stay strong and stay long, IMO...besides the delays, nothing has changed here except attitude and PPS, IMO. The tech is still here! Good luck and have a great Friday! $ENDV

[sello]

The earlier studies we're not in a preclinical setting. The pelimanary research showed significant reduction in inflammation. I am too busy right now too dig it up but it is there. These current trials are the first preclinicals the company has conducted.